Odiparcil (Synonyms: SB-424323) |
Catalog No.GC36792 |
Odiparcil(SB-424323)은 부작용 위험 감소와 관련된 항혈전 활성을 갖는 경구 활성 베타-d-티옥실로사이드 유사체입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 137215-12-4
Sample solution is provided at 25 µL, 10mM.
Odiparcil (SB-424323) is an orally active beta-d-thioxyloside analog with antithrombotic activity associated with a reduced risk of adverse bleeding events. Odiparcil (SB-424323) is indirect thrombin inhibitor that exerts its anticoagulant effect through activation of antithrombin II (heparin cofactor II) [1][2]. Thrombin[2]
[1]. Myers AL, et al. Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin. J Clin Pharmacol. 2008 Oct;48(10):1158-70 [2]. Levy JH, et al. Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology. 2010 Sep;113(3):726-45.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *